Variables | MPA (n = 55) | LA(n = 76) | χ2 | p |
---|---|---|---|---|
Gender | Â | Â | 0.518 | 0.485 |
 Female | 24(43.6%) | 38(50.0%) |  |  |
 Male | 31(56.4%) | 38(50.0%) |  |  |
Age(years) | Â | Â | 7.452 | 0.008** |
> 65 | 20(36.4%) | 46(60.5%) | Â | Â |
≤ 65 | 35(63.6%) | 30(39.5%) |  |  |
Smoking history | Â | Â | 0.191 | 0.723 |
 Ever | 26(47.3%) | 33(43.4%) |  |  |
 Never | 29(52.7%) | 43(56.6%) |  |  |
Tumor size(cm) | Â | Â | 0.058 | 0.851 |
 > 3.0 | 17(30.9%) | 25(32.9%) |  |  |
 ≤ 3.0 | 38(69.1%) | 51(67.1%) |  |  |
Lymphovascular invasion | Â | Â | 1.645 | 0.225 |
 Present | 17(30.9%) | 16(21.1%) |  |  |
 Absent | 38(69.1%) | 60(78.9%) |  |  |
Tumor differentiation | Â | Â | 0.179 | 0.835 |
 Well/moderate | 43(78.2%) | 57(75.0%) |  |  |
 Poor | 12(21.8%) | 19(25.0%) |  |  |
N status | Â | Â | 4.291 | 0.03* |
 N0 | 31(56.4%) | 56(73.7%) |  |  |
 N1/N2 | 24(43.6%) | 20(26.3%) |  |  |
Pleural invasion | Â | Â | 4.117 | 0.036* |
 Present | 15(27.3%) | 10(13.2%) |  |  |
 Absent | 40(72.7%) | 66(86.8%) |  |  |
Stage | Â | Â | 5.701 | 0.024* |
 I/II | 47(85.5%) | 51(67.1%) |  |  |
 III/IV | 8(14.5%) | 25(32.9%) |  |  |
Mutation status | Â | Â | Â | Â |
EGFR mutation | 42(76.4%) | 42(55.3%) | 6.175 | 0.016* |
EML4-ALK fusion | 3(5.5%) | 1(1.3%) | 1.846 | 0.309 |
ROS1 fusion | 6(10.9%) | 1(1.3%) | 5.806 | 0.041* |